Effects of inpatient traditional, complementary and integrative medicine (TCIM) care in Germany.
Effects of the Clinical Application of TCIM Procedures During Inpatient Stays in Germany - a Multicenter Observational Study
This project will see if a routine package of inpatient TCIM therapies—like hyperthermia, exercise, mind‑body medicine, herbal and nutritional therapies including fasting—helps adults with chronic diseases admitted to participating German hospitals.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 2500 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | Charite University, Berlin, Germany Academic / other |
| Locations | 3 sites (Bamberg and 2 other locations) |
| Trial ID | NCT07040475 on ClinicalTrials.gov |
What this trial studies
This observational project follows patients who begin routine inpatient TCIM care at three German hospitals to collect data on outcomes and safety. Patients receive a combination of evidence-based TCIM approaches such as hyperthermia, exercise therapy, mind‑body medicine, phytotherapy, nutritional therapy and fasting as part of usual care. Data are collected from the start of treatment and during the hospital stay to describe symptoms, functional status, adverse events and healthcare use. The design is non-randomized and evaluates the real-world effects of standard TCIM packages under current reimbursement arrangements.
Who should consider this trial
Good fit: Ideal candidates are adults with chronic diseases who begin inpatient TCIM treatment within 24 hours at one of the participating hospitals and can give written informed consent.
Not a fit: Patients who are pregnant or breastfeeding, have severe cognitive impairment or insufficient language skills, are enrolled in another clinical study, or are not receiving inpatient TCIM likely will not benefit from this project.
Why it matters
Potential benefit: If successful, the findings could support wider use and reimbursement of integrated inpatient TCIM approaches and show improvements in patient symptoms, function, or safety.
How similar studies have performed: Components of TCIM such as exercise, mind‑body therapies, phytotherapy and nutritional approaches have some supporting evidence, but systematic evaluations of combined inpatient TCIM packages are limited.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion criteria: * Beginning (first 24 hours) inpatient TCIM treatment at Immanuel Hospital Berlin, Bamberg Hospital, or Evangelische Kliniken Essen-Mitte * Written consent form Exclusion criteria: * Insufficient language skills * Dementia or other severely impairing cognitive disorders * Pregnancy or breastfeeding * Participation in a clinical study
Where this trial is running
Bamberg and 2 other locations
- Sozialstiftung Bamberg, Klinikum Bamberg — Bamberg, Germany (Recruiting)
- Charité Hochschulambulanz für Naturheilkunde am Immanuel Krankenhaus, Institut für Sozialmedizin, Epidemiologie und Gesundheitsökonomie, Charité - Universitätsmedizin Berlin — Berlin, Germany (Recruiting)
- Klinik für Naturheilkunde und Integrative Medizin, KEM — Essen, Germany (Recruiting)
Study contacts
- Study coordinator: Michael Jeitler, PD Dr.
- Email: naturheilkunde@charite.de
- Phone: 03080505682
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.